X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (75783) 75783
Newsletter (1131) 1131
Newspaper Article (594) 594
Book Chapter (328) 328
Magazine Article (158) 158
Dissertation (124) 124
Publication (69) 69
Transcript (37) 37
Book / eBook (35) 35
Conference Proceeding (31) 31
Reference (27) 27
Web Resource (6) 6
Book Review (5) 5
Journal / eJournal (4) 4
Streaming Video (4) 4
Paper (2) 2
Trade Publication Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58250) 58250
male (26917) 26917
female (26071) 26071
middle aged (20592) 20592
oncology (18180) 18180
aged (17870) 17870
adult (16067) 16067
hematology (15690) 15690
animals (11968) 11968
lymphomas (11593) 11593
b-cell lymphoma (11298) 11298
lymphoma (9890) 9890
cancer (9501) 9501
prognosis (7833) 7833
b cells (7743) 7743
mice (7735) 7735
lymphoma, large b-cell, diffuse - pathology (7396) 7396
expression (7232) 7232
aged, 80 and over (7038) 7038
immunology (6951) 6951
rituximab (6827) 6827
pathology (6327) 6327
lymphoma, b-cell - pathology (6295) 6295
chemotherapy (6095) 6095
antineoplastic combined chemotherapy protocols - therapeutic use (5747) 5747
apoptosis (5709) 5709
adolescent (5651) 5651
non-hodgkins-lymphoma (5471) 5471
treatment outcome (5396) 5396
research (5393) 5393
leukemia (5354) 5354
lymphocytes b (4856) 4856
immunohistochemistry (4811) 4811
lymphoma, large b-cell, diffuse - drug therapy (4611) 4611
hemic and lymphatic diseases (4582) 4582
child (4280) 4280
survival (4177) 4177
care and treatment (4132) 4132
b-cells (4080) 4080
diagnosis, differential (4034) 4034
gene expression (3973) 3973
analysis (3961) 3961
b-lymphocytes - immunology (3875) 3875
lymphocytes (3858) 3858
diagnosis (3831) 3831
health aspects (3799) 3799
cell biology (3765) 3765
therapy (3707) 3707
flow cytometry (3681) 3681
retrospective studies (3595) 3595
lymphoma, large b-cell, diffuse - diagnosis (3559) 3559
proteins (3559) 3559
genetic aspects (3488) 3488
chronic lymphocytic-leukemia (3445) 3445
disease (3373) 3373
cell line, tumor (3333) 3333
tumors (3315) 3315
leukemia, lymphocytic, chronic, b-cell - pathology (3285) 3285
diffuse large b-cell lymphoma (3268) 3268
antineoplastic agents - therapeutic use (3223) 3223
lymphoma, b-cell - genetics (3209) 3209
activation (3174) 3174
mutation (3137) 3137
biopsy (3035) 3035
medicine, research & experimental (2924) 2924
tumor cells, cultured (2903) 2903
immunophenotyping (2894) 2894
chronic lymphocytic leukemia (2877) 2877
lymphoma, b-cell - drug therapy (2853) 2853
t cells (2808) 2808
young adult (2782) 2782
lymphoma, large b-cell, diffuse - genetics (2777) 2777
b-cell (2750) 2750
non-hodgkin's lymphomas (2737) 2737
medicine & public health (2712) 2712
abridged index medicus (2702) 2702
leukemia, lymphocytic, chronic, b-cell - drug therapy (2671) 2671
immunotherapy (2661) 2661
signal transduction (2619) 2619
biochemistry & molecular biology (2609) 2609
polymerase chain reaction (2601) 2601
lymphoma, b-cell - diagnosis (2595) 2595
risk factors (2572) 2572
neoplasm staging (2569) 2569
leukemia, lymphocytic, chronic, b-cell - genetics (2536) 2536
lymphoma, b-cell - immunology (2527) 2527
lymphoma, b-cell, marginal zone - pathology (2516) 2516
child, preschool (2511) 2511
patients (2461) 2461
follicular lymphoma (2444) 2444
immune system diseases (2437) 2437
gene (2407) 2407
follow-up studies (2385) 2385
neoplasms (2345) 2345
research article (2335) 2335
classification (2326) 2326
antibodies, monoclonal - therapeutic use (2294) 2294
lymphoma, large b-cell, diffuse (2287) 2287
b-lymphocytes - metabolism (2282) 2282
lymphoma, non-hodgkin - pathology (2279) 2279
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (71513) 71513
Japanese (1543) 1543
German (1490) 1490
French (1387) 1387
Chinese (1039) 1039
Spanish (700) 700
Italian (688) 688
Russian (672) 672
Polish (237) 237
Korean (226) 226
Portuguese (146) 146
Czech (93) 93
Hungarian (92) 92
Danish (56) 56
Dutch (56) 56
Romanian (55) 55
Turkish (43) 43
Serbian (29) 29
Norwegian (26) 26
Croatian (20) 20
Swedish (20) 20
Bulgarian (18) 18
Slovak (17) 17
Hebrew (16) 16
Finnish (14) 14
Persian (6) 6
Ukrainian (6) 6
Lithuanian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Galician (1) 1
Greek (1) 1
Indonesian (1) 1
Manx (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Primary care, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9822, pp. 1234 - 1244
Summary Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest growing human tumour... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | AFRICAN CHILDREN | PLASMODIUM-FALCIPARUM | ACUTE LYMPHOBLASTIC-LEUKEMIA | B-CELL LYMPHOMAS | ACTIVE ANTIRETROVIRAL THERAPY | C-MYC | NON-HODGKINS-LYMPHOMA | EPSTEIN-BARR-VIRUS | CHILDRENS ONCOLOGY GROUP | ACUTE MALARIA | Transcriptional Activation - genetics | Prognosis | HIV Infections - epidemiology | Humans | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Child, Preschool | Infant | Burkitt Lymphoma - epidemiology | Incidence | Endemic Diseases | Malaria - epidemiology | Burkitt Lymphoma - genetics | Epstein-Barr Virus Infections - genetics | Child | Burkitt Lymphoma - drug therapy | Epstein-Barr Virus Infections - epidemiology | Poverty - statistics & numerical data | Health Services Accessibility - statistics & numerical data | Burkitt Lymphoma - virology | Cross-Sectional Studies | Epstein-Barr Virus Infections - virology | Risk Factors | Rituximab | Epstein-Barr Virus Infections - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Proto-Oncogene Proteins c-myc - genetics | Translocation, Genetic - genetics | Care and treatment | Immunocompromised host | Patient outcomes | Genetic aspects | Risk factors | Burkitt's lymphoma | Diseases | Causes of | Practice guidelines (Medicine) | Diagnosis | Low income groups | Chemotherapy | Consolidation | Malaria | Human immunodeficiency virus--HIV | Cyclin-dependent kinases | Drug therapy | Epidemiology | Cancer therapies | Cancer | Apoptosis | Tumors
Journal Article
American journal of hematology, ISSN 0361-8609, 2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2018, Volume 19, Issue 9, p. 2475
With the introduction of next generation sequencing methods, such as RNA sequencing, it has become apparent that alterations in the non-coding regions of our... 
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | MULTIPLE-MYELOMA | chronic lymphocytic leukemia (CLL) | acute lymphoblastic leukemia (ALL) | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | SOMATIC MUTATIONS | TRANSCRIPTIONAL FINGERPRINTS | diffuse large B-cell lymphoma (DLBCL) | burkitt lymphoma (BL) | BURKITT-LYMPHOMA | gene regulation | circular RNA | POOR-PROGNOSIS | PROFILING REVEALS | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM) | EXPRESSION | PROMOTES | LNCRNA | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Lymphomas | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites
Journal Article
Journal Article
Journal Article
Investigational new drugs, ISSN 1573-0646, 2018, Volume 37, Issue 2, pp. 297 - 306
...) dimer, in patients with relapsed or refractory (R/R) CD70-positive non-Hodgkin lymphoma (NHL... 
Mantle-cell lymphoma | Medicine & Public Health | Pyrrolobenzodiazepine dimer (PBD) | Grade 3 follicular lymphoma | Diffuse, large B cell, lymphoma (DLBCL) | Oncology | Pharmacology/Toxicology | CD70 antigen | Antibody-drug conjugate | Diffuse | large B cell | ONCOLOGY | lymphoma (DLBCL) | PLUS RITUXIMAB | PHARMACOLOGY & PHARMACY | OUTCOMES | Prognosis | Follow-Up Studies | CD27 Ligand - antagonists & inhibitors | Humans | Middle Aged | Lymphoma, Mantle-Cell - pathology | Salvage Therapy | Immunoconjugates - pharmacokinetics | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Tissue Distribution | CD27 Ligand - metabolism | Lymphoma, B-Cell - immunology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Immunoconjugates - therapeutic use | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - metabolism | Lymphoma, B-Cell - drug therapy | CD27 Ligand - immunology | Lymphoma, B-Cell - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Recurrence, Local - metabolism | Antibodies, Monoclonal - pharmacokinetics | Lymphoma, Mantle-Cell - drug therapy | Maximum Tolerated Dose | Lymphoma, Mantle-Cell - immunology | Lymphoma, B-Cell - pathology | Benzodiazepines - chemistry | Pyrroles - chemistry | Aged | Drug Resistance, Neoplasm - drug effects | Thrombocytopenia | Anemia | Fatigue | Nausea | Exposure | Lymphoma | Patients | Anticancer properties | Membrane proteins | Proteins | Studies | Lymphocytes B | Mantle cell lymphoma | Antitumor activity | Remission | Lymphomas | Dimers | Mantle | Drug dosages | B-cell lymphoma | Phase I Studies
Journal Article